Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in Participants With Chronic Kidney Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 6, 2006

Primary Completion Date

October 24, 2016

Study Completion Date

October 31, 2016

Conditions

AnemiaChronic Kidney DiseaseChronic Renal FailurePure Red Cell Aplasia

Interventions

DRUG

Peginesatide

Peginesatide injection

Trial Locations (4)

Research Facility, Paris

Research Facility, Erlangen

Research Facility, Derby

Research Facility, London